CV-1153

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCV-1153
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionCaspase inhibitors
TargetsCaspase
Therapy Area/IndicationsMultiple Organ FailureMyocardial InfarctionStroke +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxim Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxim Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMultiple Organ FailureMyocardial InfarctionStroke +[5] 

Other Information

ATC CodeN/A
Related LinksN/A